RNXT•benzinga•
RenovoRx Announces Initial Revenues From RenovoCath Commercialization, And Provides Update On Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 1, 2025 by benzinga